September 13, 2019
Anokion Presents New Data Describing Transformative Therapeutic Approach for Treatment of Multiple Sclerosis at ECTRIMS Congress
Induction of Antigen-Specific Immune Tolerance Using Proprietary Technology Represents Novel, Targeted Treatment Modality for Autoimmune Diseases CAMBRIDGE, Mass. & LAUSANNE,…